More programs, more candles, more light.

CIRM Webcast: Video Archive

The recordings of CIRM's first scientific meeting, which ran from October 1 through October 2, 2005, are archived on this page and are accessible as video on demand (VOD).

These files are large, and you'll need at least a broadband (Cable/DSL) connection to view them. The videos stream at 225Kbps. You'll need the Real Player to view these videos. Download RealPlayer

Speaker	Speech Title	Length (min)	Link
Zach Hall, Ph.D., President, CIRM	Welcome	10:02	View
Joan Samuelson, J.D., Member, ICOC	Welcome	6:05	View
Robert Klein, Chairman, ICOC	Welcome	16:52	View
Session I
George Daley, M.D., Ph.D., Harvard Medical School	Intro - Cellular Therapeutics: Clinical State of the Art and Challenges for the Future	6:13	View
Rob Negrin, M.D., Stanford University	Hematopoietic Stem Cell Transplantation: Where We Have Been and Where We Are Going	29:21	View
Jeff Bluestone, Ph.D., University of California, San Francisco	A Cure for Type I Diabetes	32:00	View
Olle Lindvall, M.D., Ph.D., University of Lund, Sweden	Stem Cell Therapy for Human Brain Disease: How Can We Make It Work?	25:23	View
Session II
Edward Penhoet, Ph.D., Vice Chair, ICOC	Intro - Stem Cells and Therapies: Lessons from the FDA and Industry	2:39	View
Jane Lebkowski, Ph.D., Geron Corporation	Preclinical Studies to Support Clinical Testing of Stem Cell-Based Therapies	18:06	View
Alan Smith, Ph.D., Cognate Therapeutics, Inc.	GMP Banking, Manufacturing and Quality Control of Stem Cells for Clinical Use	25:38	View
Donald Fink, Ph.D., Food and Drug Administration	Developing Stem Cell-Based Therapies: Engaging the FDA	30:56	View
Session III
Fred Gage, Ph.D., The Salk Institute	Intro - Stem Cells as Tools for Disease Research and Therapy	3:33	View
Rudolph Jaenisch, Ph.D., The Whitehead Institute, MIT	SCNT for Understanding Disease	26:34	View
Inder Verma, Ph.D., The Salk Institute	Molecular Manipulation of Embryonic Stem Cells	24:14	View
Peter Schultz, Ph.D.,The Scripps Research Institute	Small Molecules and High-Throughput Screening in Embryonic Stem Cells	21:24	View
Session IV
Peter Andrews, Ph.D., University of Sheffield, United Kingdom	Intro - Self-Renewal of Stem Cells	4:22	View
Haifan Lin, Ph.D., Duke University School of Medicine	Understanding Stem Cell Self-Renewal: Progress and Prospect	18:31	View
Andras Nagy, Ph.D., Mount Sinai Hospital, Toronto, Canada	Development of Tools for Studying hESC Self-Renewal	23:18	View
Martin Pera, Ph.D., The Monash Institute of Medical Research, Australia	Development of Conditions for Defined Culture and Scale-Up	18:15	View
Session V
Nissim Benvenisty, M.D., Ph.D., Hebrew University of Jerusalem, Israel	How Can We Control Differentiation of ES Cells?	20:31	View
Irving Weissman, M.D., Stanford University	Current Status of in vivo Systems to Monitor Stem Cell Differentiation and Function	39:36	View
Michael Clarke, M.D., University of Michigan	Bad Stem Cell Choices in Cancer Development	35:11	View
Session VI
Ian Duncan, Ph.D., University of Wisconsin	Intro - Bridging the Gap Between Bench and Bedside	11:48	View
David Scadden, M.D., Harvard Medical School	The Stem Cell Niche: A Drugable Target?	31:39	View
Jon Odorico, M.D., University of Wisconsin	Hurdles to Overcome in Applying hES Cells for Treatment of Diabetes	31:06	View
Hans Keirstead, Ph.D., University of California, Irvine	Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitors: A Defined Cell Population for a Defined Need	19:45	View
Summary
Roger Bingham, The Science Network	Moderator	0:00 - 2:50	View
George Daley, M.D., Ph.D., Harvard Medical School	Chair Session 1 Summary	2:51 - 28:19	View
Edward Penhoet, Ph.D., Vice Chair, ICOC	Chair Session 2 Summary	22:21	View
Fred Gage, Ph.D., The Salk Institute	Chair Session 3 Summary	20:49	View
Peter Andrews, Ph.D., University of Sheffield, United Kingdom	Chair Session 4 Summary	13:45	View
Owen Witte, M.D., University of California, Los Angeles	Chair Session 5 Summary	7:51	View
Ian Duncan, Ph.D., University of Wisconsin	Chair Session 6 Summary and General Discussion	41:10	View
Conclusion
Zach Hall, Ph.D., President, CIRM	Closing Remarks	19:32	View